These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5157211)

  • 1. [Determination of complement (C3) levels in acute hepatitis and chronic liver diseases].
    Soerensen R; Carmona A; Meléndez M; Velasco M
    Rev Med Chil; 1971 Sep; 99(9):630-40. PubMed ID: 5157211
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating conversion products of C3 in liver disease. Evidence for in vivo activation of the complement system.
    Teisberg P; Gjone E
    Clin Exp Immunol; 1973 Aug; 14(4):509-14. PubMed ID: 4201114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BA and SH antigen in chronic hepatitis.
    Grob PJ; Jemelka HJ; Müller JW
    Gastroenterology; 1971 Jul; 61(1):91-5. PubMed ID: 4996714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Factors causing decrease in complement activity in chronic liver diseases].
    Tsuji T; Sato M; Nozaki H; Mizuno Y; Kosaka K
    Igaku To Seibutsugaku; 1970 Oct; 81(4):155-61. PubMed ID: 5531565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of complement activity in chronic liver disease].
    Di Simone A; Coraggio F; Riegler G; Ciotola R
    Minerva Dietol Gastroenterol; 1977; 23(3):137-44. PubMed ID: 618090
    [No Abstract]   [Full Text] [Related]  

  • 6. [Status of various factors of the complement system in chronic and acute hepatitis].
    Del Rey Calero J; Garcia de Lomas J; Gómez Morillo O; García de Lomas E; Miño G
    Rev Clin Esp; 1976 Jun; 141(6):515-23. PubMed ID: 968086
    [No Abstract]   [Full Text] [Related]  

  • 7. [The C3, C3 Att and C4 fractions of complement in chronic hepatitis: preliminary data].
    Riegler G; Ciotola R; Di Simone A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(4):200-3. PubMed ID: 952675
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum complement and hepatic diseases].
    Kourilsky O; Leroy C; Peltier AP
    Nouv Presse Med; 1973 Jun; 2(25):1720. PubMed ID: 4718548
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of serum complement in chronic liver diseases and in acute hepatic insufficiency].
    Naccarato R; Farini R; Chiaramonte M; Meani A; Giordano C; Gritti G
    Minerva Gastroenterol; 1976; 22(3):213-8. PubMed ID: 1004756
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum levels of C3 and cholinesterase in various diseases of the liver.
    Jorge AD; Sanchez D
    Acta Hepatogastroenterol (Stuttg); 1976 Feb; 23(1):19-25. PubMed ID: 1258598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The complement system in hepatopathies].
    De la Tour B; Kazatchkine M
    Ann Med Interne (Paris); 1985; 136(3):222-4. PubMed ID: 3161444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes in chronic hepatitis.
    Fodor O; Parau N; Fodor I; Radu D; Abrudan O
    Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):172-6. PubMed ID: 941620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune mechanisms in chronic liver diseases].
    Fodor O; Părău N; Urcan S; Dejica D; Fodor I
    Med Interne; 1975; 13(4):283-9. PubMed ID: 1243198
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic aggressive hepatitis with low and normal serum complement levels].
    Díaz-Rubio Garcia M; Enríquez L; Díaz-Rubio garcía E
    Rev Esp Enferm Apar Dig; 1977 Apr; 50(1):31-6. PubMed ID: 860079
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complement activity in chronic liver diseases].
    Ghidini O; Del Campo A; Tomasi A; Franzoni A
    G Clin Med; 1970 Jul; 51(7):568-79. PubMed ID: 5527274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Complement (C3) in hepatic diseases: its prognosis value].
    Velasco M; Giaconi J; Katz R; Ruíz A
    Rev Med Chil; 1972 Nov; 100(11):1332-6. PubMed ID: 4658364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood levels of immunoglobulins (IgA, IgG and IgM) and hepatopathies].
    Squadrito G; Ceruso D; Quartarone M; Monacciani U
    Boll Soc Ital Biol Sper; 1973 Nov; 49(21):1260-4. PubMed ID: 4802145
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serum concentration of the third component of complement beta-1C-beta-1A in liver disease.
    Fox RA; Dudley FJ; Sherlock S
    Gut; 1971 Jul; 12(7):574-8. PubMed ID: 4997691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.